Myrisk
Payments companies reported to CMS as associated with Myrisk. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Myrisk, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Myrisk
These are the largest totals companies reported as associated with Myrisk. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Adam Brufsky | Pittsburgh, PA | $180,740.88 | |
| Royce Adkins | Nashville, TN | Obstetrics & Gynecology | $93,372.06 |
| Candace Westgate | Indianapolis, IN | Obstetrics & Gynecology | $79,469.54 |
| Sean Raj | Dallas, TX | Diagnostic Radiology | $77,705.11 |
| Burton Brodsky | Sylvania, OH | Obstetrics & Gynecology | $76,026.85 |
| Alfredo Santillan Gomez | San Antonio, TX | Surgical Oncology | $74,668.19 |
| Devesh Pandya | Houston, TX | Hematology & Oncology | $31,876.80 |
| Stacy Smith-Foley | Little Rock, AR | Diagnostic Radiology | $31,742.24 |
| David Weintritt | Alexandria, VA | Surgery | $19,588.16 |
| Kirsten Stuber | Tyler, TX | Family | $18,537.69 |
Prescribed Myrisk?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.